|
Report Date : |
19.05.2012 |
IDENTIFICATION DETAILS
|
Name : |
LAILA NUTRACEUTICALS |
|
|
|
|
Registered
Office : |
40-15-14 Brindavan Colony, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2012 |
|
|
|
|
Year of
Establishment : |
2005 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.50.000 Millions |
|
|
|
|
Legal Form : |
Partnership Concern with an Unlimited Liability of the Partners |
|
|
|
|
Line of Business
: |
Manufacturer of
Herbal Extracts. |
|
|
|
|
No. of Employees
: |
500 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (49) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 200000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an
established partnership concern with satisfactory track. Trade relations are
reported as fair. Business is active. Payments are usually correct and as per
commitments. The concern can
be considered normal for business dealings at usual trade terms and
conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INFORMATION PARTED BY
|
Name : |
Mr. Subharam |
|
Designation : |
Export Manager |
|
Contact No.: |
91-866-2473468 |
|
Date : |
18.05.2012 |
LOCATIONS
|
Registered Office : |
40-15-14 Brindavan Colony, |
|
Tel. No.: |
91-866-2473468 |
|
Fax No.: |
91-866-2475278 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
5 Acre |
|
Location : |
Owned |
|
|
|
|
Factory : |
6 and 7, Auto Nagar, Shed No.6 and 7, Autonagar, Vijayaeada – 520 007,
|
|
Area : |
24000 Sq. ft. |
|
Location : |
Owned |
|
|
|
|
Chennai Office: |
No.7, |
|
Tel. No.: |
91-44-26565923 |
|
Fax No.: |
91-44-26565924 |
|
E-Mail : |
|
|
|
|
|
Branches : |
JRD Tata
Industrial Estate, |
|
Location : |
Owned |
PARTNERS
|
Name : |
Mr. G. Gangaraju |
|
Designation : |
Partner |
|
Qualification : |
B. Pham |
|
|
|
|
Name : |
Mr. G. Laila |
|
Designation : |
Partner |
|
Qualification : |
BA |
|
|
|
|
Name : |
Mr. G V.K Rangraj |
|
Designation : |
Partner |
|
Qualification : |
BE |
|
|
|
|
Name : |
Mr. G.M Ramraju |
|
Designation : |
Partner |
|
Qualification : |
B. Pham |
KEY EXECUTIVES
|
Name : |
Mr. Subharam |
|
Designation : |
Export Manager |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of
Herbal Extracts. |
|
|
|
|
Exports : |
|
|
Products : |
Herbal Extracts |
|
Countries : |
|
|
|
|
|
Imports : |
|
|
Products : |
Herb Gracinia |
|
Countries : |
|
|
|
|
|
Terms : |
|
|
Selling : |
Cash / Credit |
|
|
|
|
Purchasing : |
Cash / Credit |
GENERAL INFORMATION
|
Customers : |
Wholesalers and Retailers
|
|
|
|
|
No. of Employees : |
500 (Approximately) |
|
|
|
|
Bankers : |
UCO Bank, Arudel
Pat Branch |
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
V.V. Raju and
Associates Chartered
Accountants |
|
Address : |
Brindavan Colony,
|
|
Tel. No.: |
91-866-2474862 |
|
|
|
|
Associates/Subsidiaries : |
Activity :
Producer of Sugar Beet
Activity : Manufacturer of Writing And Printing Papers
|
CAPITAL STRUCTURE
As on 31.03.2012
|
Capital Investment : |
|
|
Owned : |
Rs.50.000 Millions (Estimated) |
|
Borrowed : |
-- |
|
Total : |
Rs.50.000
Millions (Estimated) |
FINANCIAL DATA
[all figures are
in Rupees Millions]
|
Particulars |
|
31.03.2012 |
31.03.2011 |
|
Sales Turnover (Approximately) |
|
720.000 |
700.000 |
Expected Sales (2012-13) : Rs.750.000 Millions
The above information has been parted by Mr. Subharam
Note : Sole Proprietory and Partnership concerns are
exempted from filing their financials with the Government Authorities or
Registry Records.
LOCAL AGENCY FURTHER INFORMATION
|
Check List by Info Agents |
Available in Report (Yes / No) |
|
1) Year of Establishment |
Yes |
|
2) Locality of the firm |
Yes |
|
3) Constitutions of the firm |
Yes |
|
4) Premises details |
No |
|
5) Type of Business |
Yes |
|
6) Line of Business |
Yes |
|
7) Promoter’s background |
Yes |
|
8) No. of employees |
Yes |
|
9) Name of person contacted |
Yes |
|
10) Designation of contact person |
Yes |
|
11) Turnover of firm for last two years |
Yes |
|
12) Profitability for last three years |
No |
|
13) Reasons for variation <> 20% |
-- |
|
14) Estimation for coming financial year |
Yes |
|
15) Capital in the business |
Yes |
|
16) Details of sister concerns |
Yes |
|
17) Major suppliers |
No |
|
18) Major customers |
Yes |
|
19) Payments terms |
Yes |
|
20) Export / Import details (if applicable) |
Yes |
|
21) Market information |
-- |
|
22) Litigations that the firm / promoter |
-- |
|
23) Banking Details |
Yes |
|
24) Banking facility details |
No |
|
25) Conduct of the banking account |
-- |
|
26) Buyer visit details |
-- |
|
27) Financials, if provided |
Yes |
|
28) Incorporation details, if applicable |
No |
|
29) Last accounts filed at ROC |
No |
|
30) Major Shareholders, if available |
No |
Trade References
WEBSITE DETAILS
PROFILE
Subject, an enterprise into drug discovery, was established in 2008 with the main objective of finding new therapeutic leads from phytopharmaceuticals and NCE’s.
Subject is a part of the Laila group of companies, based at
At the global level, Laila is recognized
for its pioneering work in integrating phytopharmaceuticals and modern
science for developing premium high quality novel bio-active leads
from botanicals. Laila employs modern techniques to standardize the
phytochemicals and principal ingredients to study various novel uses and
therapeutic applications.
With over 32 years of expertise in the Herbal industry, Laila is the trusted
partner for many leading pharmaceutical companies in
National R and D award winner for best
in-house R and D
In 2007, in the chemical and allied industry segment, Laila was adjudged the best R and D driven Indian enterprise over many other bigger companies.
IP−intensive and R and D driven
enterprise
Laila Impex is an R and D driven enterprise. Over 20 patents were
filed by Laila in 2007 alone, compared to the 40 odd patents in its entire
history. The patent portfolio comprises of more than 10
Laila Phramaceuticals is chaired by Dr. Ganga Raju. Dr. C.N. Ramchand heads the
company as its President and CEO. Mr. Kiran Bhupatiraju and Mr. Rama Raju are
key members of the executive team and are full time directors. Laila
Pharmaceuticals is fully supported for its scientific endeavors by senior
scientists from Laila group.
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.88 |
|
|
1 |
Rs.86.46 |
|
Euro |
1 |
Rs.69.49 |
INFORMATION DETAILS
|
Information
Gathered by : |
PJA |
|
|
|
|
Report Prepared
by : |
NTH |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
49 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.